Oxford Biomedica gears up for the clinic with manufacturing acquisition
This article was originally published in Scrip
Executive Summary
Oxford BioMedica is to acquire a manufacturing facility based in Oxford, UK, from Recipharm Cobra Biologics for £1.9 million.